X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs BIOCON LTD - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS BIOCON LTD J.B.CHEMICALS/
BIOCON LTD
 
P/E (TTM) x 15.0 82.9 18.1% View Chart
P/BV x 2.4 7.8 30.4% View Chart
Dividend Yield % 0.2 0.2 103.0%  

Financials

 J.B.CHEMICALS   BIOCON LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
BIOCON LTD
Mar-17
J.B.CHEMICALS/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs3181,162 27.4%   
Low Rs200483 41.3%   
Sales per share (Unadj.) Rs148.0194.6 76.1%  
Earnings per share (Unadj.) Rs19.134.4 55.5%  
Cash flow per share (Unadj.) Rs23.948.3 49.6%  
Dividends per share (Unadj.) Rs0.501.00 50.0%  
Dividend yield (eoy) %0.20.1 158.8%  
Book value per share (Unadj.) Rs128.9241.9 53.3%  
Shares outstanding (eoy) m84.82200.00 42.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.2 41.4%   
Avg P/E ratio x13.623.9 56.7%  
P/CF ratio (eoy) x10.817.0 63.4%  
Price / Book Value ratio x2.03.4 59.0%  
Dividend payout %2.62.9 90.1%   
Avg Mkt Cap Rs m21,951164,440 13.3%   
No. of employees `0002.79.2 29.6%   
Total wages/salary Rs m1,8417,470 24.6%   
Avg. sales/employee Rs Th4,590.94,213.9 108.9%   
Avg. wages/employee Rs Th673.4809.0 83.2%   
Avg. net profit/employee Rs Th592.1745.2 79.5%   
INCOME DATA
Net Sales Rs m12,55138,911 32.3%  
Other income Rs m5421,571 34.5%   
Total revenues Rs m13,09340,482 32.3%   
Gross profit Rs m2,0559,795 21.0%  
Depreciation Rs m4122,772 14.9%   
Interest Rs m96260 36.8%   
Profit before tax Rs m2,0888,334 25.1%   
Minority Interest Rs m0163 -0.2%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,616 29.0%   
Profit after tax Rs m1,6196,881 23.5%  
Gross profit margin %16.425.2 65.0%  
Effective tax rate %22.519.4 115.9%   
Net profit margin %12.917.7 72.9%  
BALANCE SHEET DATA
Current assets Rs m7,77840,477 19.2%   
Current liabilities Rs m4,35816,783 26.0%   
Net working cap to sales %27.260.9 44.7%  
Current ratio x1.82.4 74.0%  
Inventory Days Days5560 91.7%  
Debtors Days Days8083 96.6%  
Net fixed assets Rs m5,71345,073 12.7%   
Share capital Rs m1701,000 17.0%   
"Free" reserves Rs m10,54747,377 22.3%   
Net worth Rs m10,93748,377 22.6%   
Long term debt Rs m021,082 0.0%   
Total assets Rs m15,57493,942 16.6%  
Interest coverage x22.833.1 69.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.4 194.6%   
Return on assets %11.07.6 144.8%  
Return on equity %14.814.2 104.1%  
Return on capital %20.012.6 158.3%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889NA-   
Fx inflow Rs m6,16912,988 47.5%   
Fx outflow Rs m1,2857,899 16.3%   
Net fx Rs m4,8845,089 96.0%   
CASH FLOW
From Operations Rs m1,3976,400 21.8%  
From Investments Rs m-320-4,985 6.4%  
From Financial Activity Rs m-1,196-1,775 67.4%  
Net Cashflow Rs m-102-473 21.6%  

Share Holding

Indian Promoters % 55.4 40.4 137.1%  
Foreign collaborators % 0.3 20.6 1.5%  
Indian inst/Mut Fund % 3.4 8.4 40.4%  
FIIs % 3.9 10.7 36.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 19.9 185.9%  
Shareholders   30,437 109,995 27.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 23, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS